The aim of this trial was to study the duration of immunity conferred by a standard protocol of vaccination with HIPRABOVIS® SOMNI/Lkt based on an evaluation of serological response and lung lesions.
Duration of immunity conferred after vaccination with HIPRABOVIS® SOMNI/LKT in young calves
Publications
Cattle
Appeared in
ANEMBE Congress, 2017
The results indicate that vaccination with HIPRABOVIS® SOMNI/Lkt induced a significant response to anti-Lkt antibodies and antibodies to H. somni. These antibodies persisted in vaccinated animals until week 40 after vaccination. The vaccinated animals had lower scores for both for the percentage and severity of lung lesions than the non-vaccinated calf group.